应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SNY 赛诺菲安万特
未开盘 11-03 16:00:00 EST
45.33
-0.22
-0.48%
盘后
45.33
+0.00
0.00%
19:30 EST
最高
45.70
最低
45.06
成交量
563.05万
今开
45.53
昨收
45.55
日振幅
1.42%
总市值
1,086亿
流通市值
979.13亿
总股本
23.96亿
成交额
2.55亿
换手率
0.26%
流通股本
21.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜赛诺菲安万特盘中上涨4.01%，Q3利润大超预期且Dupixent销售强劲
行情直击 · 10-30
异动解读｜赛诺菲安万特盘中上涨4.01%，Q3利润大超预期且Dupixent销售强劲
盘前异动 | 业绩逊预期，英特尔盘前暴跌23%、亚马逊跌7%；绩优股Rivian上涨7%，赛诺菲涨4%；Roblox、Twilio绩后跌18%，Reddit暴跌21%
老虎资讯综合 · 10-30
盘前异动 | 业绩逊预期，英特尔盘前暴跌23%、亚马逊跌7%；绩优股Rivian上涨7%，赛诺菲涨4%；Roblox、Twilio绩后跌18%，Reddit暴跌21%
异动解读｜赛诺菲安万特盘前上涨3.01%，Q3利润大超预期且Dupixent销售强劲
行情直击 · 10-30
异动解读｜赛诺菲安万特盘前上涨3.01%，Q3利润大超预期且Dupixent销售强劲
赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧
智通财经 · 10-30
赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧
异动解读｜赛诺菲安万特夜盘上涨3.18%，Dupixent第三季度销售强劲增长
行情直击 · 10-30
异动解读｜赛诺菲安万特夜盘上涨3.18%，Dupixent第三季度销售强劲增长
财报前瞻 | 赛诺菲安万特本季度营收预计增2.57%，机构观点偏中性
财报Agent · 10-23
财报前瞻 | 赛诺菲安万特本季度营收预计增2.57%，机构观点偏中性
异动解读｜赛诺菲安万特盘中上涨3.16%，炎症药物Duvakitug中期数据提振情绪
行情直击 · 10-20
异动解读｜赛诺菲安万特盘中上涨3.16%，炎症药物Duvakitug中期数据提振情绪
赛诺菲(SNY.US)启动一项10亿美元的加速股票回购协议。
智通财经 · 10-05
赛诺菲(SNY.US)启动一项10亿美元的加速股票回购协议。
异动解读｜赛诺菲安万特盘前下跌3.15%，前一交易日大涨逾9%后遭获利回吐
行情直击 · 10-02
异动解读｜赛诺菲安万特盘前下跌3.15%，前一交易日大涨逾9%后遭获利回吐
异动解读｜赛诺菲安万特夜盘下跌3.17%，前一交易日大涨逾9%后遭获利回吐
行情直击 · 10-02
异动解读｜赛诺菲安万特夜盘下跌3.17%，前一交易日大涨逾9%后遭获利回吐
赛诺菲(SNY.US)涨9.4%，公司预测2027财年收入和利润将超出预期。
智通财经 · 10-01
赛诺菲(SNY.US)涨9.4%，公司预测2027财年收入和利润将超出预期。
加拿大卫生部：赛诺菲安万特加拿大公司召回运输途中可能受冻的胰岛素笔及胰岛素药盒。
智通财经 · 09-26
加拿大卫生部：赛诺菲安万特加拿大公司召回运输途中可能受冻的胰岛素笔及胰岛素药盒。
赛诺菲(SNY.US)的VaxRabneo获得欧盟监管机构批准用于狂犬病预防。
智通财经 · 09-18
赛诺菲(SNY.US)的VaxRabneo获得欧盟监管机构批准用于狂犬病预防。
赛诺菲(SNY.US)长效RSV单抗新适应症申报上市
智通财经 · 08-07
赛诺菲(SNY.US)长效RSV单抗新适应症申报上市
异动解读｜赛诺菲盘中下跌6.38%，新帅首秀上调指引难掩新药管线断层隐忧
行情直击 · 07-30
异动解读｜赛诺菲盘中下跌6.38%，新帅首秀上调指引难掩新药管线断层隐忧
异动解读｜赛诺菲盘前下跌3.08%，新帅首秀上调指引难掩新药管线断层隐忧
行情直击 · 07-30
异动解读｜赛诺菲盘前下跌3.08%，新帅首秀上调指引难掩新药管线断层隐忧
新帅首秀上调业绩指引股价反跌，赛诺菲(SNY.US)“新药荒”成致命软肋
智通财经 · 07-30
新帅首秀上调业绩指引股价反跌，赛诺菲(SNY.US)“新药荒”成致命软肋
异动解读｜赛诺菲盘中上涨3.07%，制药板块集体走强叠加财报临近
行情直击 · 07-28
异动解读｜赛诺菲盘中上涨3.07%，制药板块集体走强叠加财报临近
异动解读｜赛诺菲盘前下跌3.23%，报43.4美元
行情直击 · 07-14
异动解读｜赛诺菲盘前下跌3.23%，报43.4美元
异动解读｜赛诺菲夜盘下跌3.23%，报42.58美元
行情直击 · 07-14
异动解读｜赛诺菲夜盘下跌3.23%，报42.58美元
加载更多
公司概况
公司名称：
赛诺菲安万特
所属市场：
NASDAQ
上市日期：
--
主营业务：
Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司，专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织：DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。
发行价格：
--
{"stockData":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"赛诺菲安万特","latestPrice":45.33,"timestamp":1793739600000,"preClose":45.55,"halted":0,"volume":5630471,"hourTrading":{"tag":"盘后","latestPrice":45.33,"preClose":45.33,"latestTime":"19:30 EST","volume":73788,"amount":3344787.9043,"timestamp":1793752205077,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004829857299670667,"floatShares":2160000000,"shares":2396000000,"eps":1.963047,"marketStatus":"未开盘","change":-0.22,"latestTime":"11-03 16:00:00 EST","open":45.53,"high":45.7,"low":45.055,"amount":255440562.00663,"amplitude":0.01416,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.963047,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793782800000},"marketStatusCode":0,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":45.55,"dividendRate":0.051745,"preHourTrading":{"tag":"盘前","latestPrice":45.57,"preClose":45.55,"latestTime":"09:29 EST","volume":38271,"amount":1743339.9188549998,"timestamp":1793716174647,"change":0.02,"changeRate":0.000439,"amplitude":0.010812},"postHourTrading":{"tag":"盘后","latestPrice":45.33,"preClose":45.33,"latestTime":"19:30 EST","volume":73788,"amount":3344787.9043,"timestamp":1793752205077,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.876943,"impliedVol":0.2973,"impliedVolPercentile":0.6454},"requestUrl":"/m/hq/s/SNY","defaultTab":"news","newsList":[{"id":"1192204368","title":"异动解读｜赛诺菲安万特盘中上涨4.01%，Q3利润大超预期且Dupixent销售强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1192204368","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192204368?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:17","pubTimestamp":1793369836,"startTime":"0","endTime":"0","summary":"10月30日，赛诺菲安万特盘中上涨4.01%，报44.86美元/股，成交额1.55亿美元。消息面上，公司第三季度业绩超出市场预期，并连续第二个季度上调全年销售和利润指引，带动股价走强。其中，核心产品Dupixent当季销售额57亿欧元，同比增长34.8%；疫苗业务销售额32亿欧元，同比下降6.6%，但药品销售与推广费用低于预期，推动利润表现明显改善。公司还表示正寻求后期资产收购，以缓解未来专利到期压力。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲业绩超预期，股价强势上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115726580","title":"盘前异动 | 业绩逊预期，英特尔盘前暴跌23%、亚马逊跌7%；绩优股Rivian上涨7%，赛诺菲涨4%；Roblox、Twilio绩后跌18%，Reddit暴跌21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115726580","media":"老虎资讯综合","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115726580?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:08","pubTimestamp":1793347693,"startTime":"0","endTime":"0","summary":"亚马逊第三季度每股收益为1.89美元，营收为2,019.4亿美元。公司最新季度业绩在营收和利润两方面均未达到市场预期。Rivian Automotive盘前上涨7%。Rivian Automotive公布的第三季度业绩超过华尔街预期，同时正在提高其新款入门级R2 SUV的产量。Rivian报告称，今年7月至9月期间共交付19,248辆汽车，高于去年同期水平。Twilio预计第四季度调整后每股收益将在1.48至1.53美元之间，而根据LSEG调查的分析师预期为每股1.49美元。赛诺菲三季度利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDTL","RDYY","INYY","AMZD","AMAA","AMZW","RVNL","RDDT",".IXIC","AZYY","AMZG","INTW","INT",".DJI","RIVC","AMZN","RBLX","INTC",".SPX","SNY","AMZU","RDDC","LINT","RBLU","AMZO","RBLY","AMZP","RIVN","AMZY","AMZZ"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119553680","title":"异动解读｜赛诺菲安万特盘前上涨3.01%，Q3利润大超预期且Dupixent销售强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=1119553680","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119553680?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:05","pubTimestamp":1793347529,"startTime":"0","endTime":"0","summary":"10月30日，赛诺菲安万特盘前上涨3.01%，报44.8285美元/股，成交额31.43万美元。消息面上，公司第三季度业绩超出市场预期，并连续第二个季度上调全年销售和利润指引，带动股价走强。核心产品Dupixent当季销售额达57亿欧元，同比增长34.8%，强劲需求对冲了疫苗业务销售额32亿欧元、同比下降6.6%的压力；同时药品销售与推广费用低于预期，进一步提振利润表现。公司亦表示，正寻求后期资产收购以缓解未来专利悬崖压力，并计划在年底前更新战略重点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲Q3利润超预期，Dupixent销售强劲","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679262507","title":"赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2679262507","media":"智通财经","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679262507?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:42","pubTimestamp":1793346170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凭借旗下畅销皮肤及哮喘药物Dupixent的需求增长，赛诺菲连续第二个季度上调全年销售和利润预期。Dupixent的强劲表现抵消了疫苗销售下滑的影响。此外，赛诺菲在药品销售和推广相关费用上的支出也低于预期。投资者等待重大收购，新药开始贡献增量投资者正在等待一项重大收购，标的很可能是处于后期开发阶段的资产，以便及时推向市场，抵消部分Dupixent销售损失。Roger称，赛诺菲预计将在年底前更新其战略优先事项。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515976.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧","news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFXG1179.USD","BBH","IHE","RSPH","BBP","APXH","MEDI","IYH","GSKH","BK4007","PPH","BK4585","FXH","FHLC","BK4588","JDOC","TMED","SNY","TRUH","PBPH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157581035","title":"异动解读｜赛诺菲安万特夜盘上涨3.18%，Dupixent第三季度销售强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1157581035","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157581035?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:26","pubTimestamp":1793345203,"startTime":"0","endTime":"0","summary":"10月30日，赛诺菲安万特夜盘上涨3.18%，报44.5美元/股，成交额19.21万美元。消息面上，公司披露第三季度Dupixent销售额57亿欧元，同比增长34.8%；同期疫苗业务销售额32亿欧元，同比下降6.6%。市场本次更关注核心重磅产品Dupixent的高增长表现。此前市场预计公司当季营收同比增长2.57%、每股收益同比下降4.85%，显示收入与利润预期原本偏谨慎。叠加公司近期已就Dupixent在加拿大新增四项适应症签署意向协议，进一步强化该产品后续放量预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲安万特夜盘上涨，Dupixent销售强劲","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107803317","title":"财报前瞻 | 赛诺菲安万特本季度营收预计增2.57%，机构观点偏中性","url":"https://stock-news.laohu8.com/highlight/detail?id=1107803317","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107803317?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:18","pubTimestamp":1792714700,"startTime":"0","endTime":"0","summary":"赛诺菲安万特将于2026年10月30日发布最新季度财报，市场关注新一季营收与利润的分化表现以及核心产品线的动能可持续性。市场一致预期本季度赛诺菲安万特营收为147.93亿美元，同比增长2.57%；预计毛利率、净利率和调整后每股收益未披露；预计每股收益为1.51美元，同比下降4.85%，预计息税前利润为47.12亿美元，同比下降2.24%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 赛诺菲安万特本季度营收预计增2.57%，机构观点偏中性","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114267327","title":"异动解读｜赛诺菲安万特盘中上涨3.16%，炎症药物Duvakitug中期数据提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1114267327","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114267327?lang=zh_cn&edition=full","pubTime":"2026-10-20 21:38","pubTimestamp":1792503517,"startTime":"0","endTime":"0","summary":"10月20日，赛诺菲安万特盘中上涨3.16%，报40.67美元，成交额1302.19万美元。消息面上，梯瓦与赛诺菲公布Duvakitug在溃疡性结肠炎和克罗恩病的2b期最新数据，显示该药在第44周仍维持较高的临床缓解、临床应答及内镜改善水平，强化了市场对其免疫炎症管线推进的预期。此前公司还接连披露Dupixent在加拿大新增四项适应症意向书、与Recursion合作项目触发里程碑付款，近期管线与商业化进展持续提供支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲安万特上涨，Duvakitug中期数据提振情绪","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673570036","title":"赛诺菲(SNY.US)启动一项10亿美元的加速股票回购协议。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673570036","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673570036?lang=zh_cn&edition=full","pubTime":"2026-10-05 21:01","pubTimestamp":1791205269,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SYLD","SPHQ","LGCF","FYLD","LYLD","SNY","DIVB","ACTV","PKW","BUYB","BK4585","MYLD","BK4588","BK4007","SHRY","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155605301","title":"异动解读｜赛诺菲安万特盘前下跌3.15%，前一交易日大涨逾9%后遭获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1155605301","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155605301?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:19","pubTimestamp":1790936340,"startTime":"0","endTime":"0","summary":"10月2日，赛诺菲安万特盘前下跌3.15%，报39.39美元/股，成交额97.22万美元。前一交易日，公司因发布乐观的财年收入及利润指引，预测将超出市场预期，股价大涨9.4%，本次回调或与短线获利盘消化有关。此外，市场关注赛诺菲与再生元围绕药物开发合作的重新谈判，有机构指出再生元需在后续产品经济条款上争取更有利条件，双方合作前景的不确定性对市场情绪构成一定压力。同时，赛诺菲此前已终止amlitelimab特应性皮炎项目的临床开发，管线风险亦受到投资者持续关注。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"赛诺菲安万特盘前下跌，获利回吐压力显现","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145662324","title":"异动解读｜赛诺菲安万特夜盘下跌3.17%，前一交易日大涨逾9%后遭获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1145662324","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145662324?lang=zh_cn&edition=full","pubTime":"2026-10-02 15:21","pubTimestamp":1790925711,"startTime":"0","endTime":"0","summary":"10月2日，赛诺菲安万特夜盘下跌3.17%，报39.38美元/股，成交额48.25万美元。前一交易日，公司因发布乐观的财年收入及利润指引，预测将超出市场预期，股价大涨9.4%。本次回调或与短线获利盘消化有关。此外，近期市场关注赛诺菲与再生元围绕药物开发合作的重新谈判。有机构指出，再生元需要在后续产品经济条款上争取更有利条件，双方合作前景的不确定性对市场情绪构成一定压力。值得注意的是，赛诺菲此前已终止amlitelimab特应性皮炎项目的临床开发，管线风险亦受到投资者持续关注。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"赛诺菲安万特夜盘下跌，获利回吐压力显现","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672506097","title":"赛诺菲(SNY.US)涨9.4%，公司预测2027财年收入和利润将超出预期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672506097","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672506097?lang=zh_cn&edition=full","pubTime":"2026-10-01 21:32","pubTimestamp":1790861550,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","SNY","BK4007","BK4585","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670224724","title":"加拿大卫生部：赛诺菲安万特加拿大公司召回运输途中可能受冻的胰岛素笔及胰岛素药盒。","url":"https://stock-news.laohu8.com/highlight/detail?id=2670224724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670224724?lang=zh_cn&edition=full","pubTime":"2026-09-26 05:34","pubTimestamp":1790372048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFXG1179.USD","BK4585","BK4007","SNY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668947167","title":"赛诺菲(SNY.US)的VaxRabneo获得欧盟监管机构批准用于狂犬病预防。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668947167","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668947167?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:31","pubTimestamp":1789727495,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SNY","EIRL","FEP","BK4585","BK4582","IE00BFXG1179.USD","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657618228","title":"赛诺菲(SNY.US)长效RSV单抗新适应症申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2657618228","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657618228?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:38","pubTimestamp":1786088335,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月7日，CDE官网公示，赛诺菲(SNY.US)尼塞韦单抗注射液一项新适应症上市申请获得受理，注册分类为3.1类。根据公开信息和临床试验进展，Insight数据库推测本次申报适应症为预防以下婴幼儿呼吸道合胞病毒(RSV)引起的下呼吸道感染：即将进入或在第二个RSV感染季期间出生的新生儿和婴儿。截图来源：CDE官网尼塞韦单抗是赛诺菲和阿斯利康联合开发的一种单剂量长效抗体疫苗，只需一剂，即可通过抗体提供快速保护，帮助预防由RSV引起的下呼吸道疾病，而无需激活免疫系统。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4588","SNY","BK4585","IPOS","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114644416","title":"异动解读｜赛诺菲盘中下跌6.38%，新帅首秀上调指引难掩新药管线断层隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1114644416","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114644416?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:06","pubTimestamp":1785420373,"startTime":"0","endTime":"0","summary":"7月30日，赛诺菲盘中下跌6.38%，报41.94美元/股，成交额1.14亿美元。消息面上，赛诺菲于当日盘前公布二季度财报，新任CEO首次亮相并上调全年业绩指引，但市场反应消极，股价不升反跌，跌幅持续扩大。在过去12个月里，受一系列负面临床试验结果拖累，赛诺菲股价已累计下跌约13%，核心产品Dupixent专利将于下个十年初到期，而公司尚未拿出足以填补收入缺口的明确替代方案，研发管线青黄不接的战略焦虑持续压制估值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119578955","title":"异动解读｜赛诺菲盘前下跌3.08%，新帅首秀上调指引难掩新药管线断层隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1119578955","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119578955?lang=zh_cn&edition=full","pubTime":"2026-07-30 18:21","pubTimestamp":1785406895,"startTime":"0","endTime":"0","summary":"7月30日，赛诺菲盘前下跌3.08%，报43.47美元/股，成交额41.72万美元。消息面上，赛诺菲于当日盘前公布二季度财报，新任CEO首次亮相并上调全年业绩指引，但市场反应消极，股价不升反跌。此前赛诺菲已接连遭遇管线挫折：7月24日宣布停止amlitelimab特应性皮炎适应症开发，6月终止riliprubart三期临床试验。在过去12个月里，受一系列好坏参半甚至负面的临床试验结果拖累，赛诺菲股价已累计下跌约13%，研发管线青黄不接的战略焦虑持续压制估值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"赛诺菲新帅首秀上调指引难掩新药管线断层隐忧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655827003","title":"新帅首秀上调业绩指引股价反跌，赛诺菲(SNY.US)“新药荒”成致命软肋","url":"https://stock-news.laohu8.com/highlight/detail?id=2655827003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655827003?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:46","pubTimestamp":1785404777,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4588","BK4585","SNY","IE00BFXG1179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130718473","title":"异动解读｜赛诺菲盘中上涨3.07%，制药板块集体走强叠加财报临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1130718473","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130718473?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:25","pubTimestamp":1785248749,"startTime":"0","endTime":"0","summary":"7月28日，赛诺菲盘中上涨3.07%，报45.585美元/股，成交额2594.27万美元。消息面上，赛诺菲将于7月30日盘前公布二季度财报（预期EPS为1.09美元），市场或存在财报前布局资金推动。同时，制药板块整体走强，辉瑞涨3.18%、默沙东涨3.07%、强生涨2.73%、礼来涨2.38%、阿斯利康涨2.28%，板块联动效应明显。此外，此前赛诺菲宣布停止amlitelimab特应性皮炎适应症开发时已明确表示不影响全年财务展望，短期负面情绪或已被消化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163046670","title":"异动解读｜赛诺菲盘前下跌3.23%，报43.4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163046670","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163046670?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:03","pubTimestamp":1784016232,"startTime":"0","endTime":"0","summary":"7月14日，赛诺菲盘前下跌3.23%，报43.4美元/股，成交额1610.54美元。赛诺菲所在的制药行业中，个股表现分化，其中辉瑞涨0.12%，强生涨0.04%，礼来跌0.07%，施贵宝跌0.27%，阿斯利康跌1.74%。Sanofi是一家全球领先的医疗保健公司，专注于患者需求并从事治疗解决方案的研究、开发、制造和营销，核心产品包括DUPIXENT、神经病学与免疫学、罕见病、肿瘤学、疫苗等业务板块。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143282410","title":"异动解读｜赛诺菲夜盘下跌3.23%，报42.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143282410","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143282410?lang=zh_cn&edition=full","pubTime":"2026-07-14 13:33","pubTimestamp":1784007235,"startTime":"0","endTime":"0","summary":"7月14日，赛诺菲夜盘下跌3.23%，报42.58美元/股，成交额1.15万美元。赛诺菲所在的制药行业中，个股表现分化，其中礼来涨0.14%，施贵宝涨0.2%，辉瑞持平，阿斯利康跌0.08%，强生跌0.22%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sanofi.com","stockEarnings":[{"period":"1week","weight":0.0821},{"period":"1month","weight":0.1355},{"period":"3month","weight":0.0596},{"period":"6month","weight":0.0498},{"period":"1year","weight":-0.0943},{"period":"ytd","weight":-0.0646}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司，专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织：DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.01689},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.017894},{"month":3,"riseRate":0.791667,"avgChangeRate":0.03072},{"month":4,"riseRate":0.625,"avgChangeRate":0.022233},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007253},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.015121},{"month":7,"riseRate":0.5,"avgChangeRate":0.015234},{"month":8,"riseRate":0.52,"avgChangeRate":-0.005736},{"month":9,"riseRate":0.52,"avgChangeRate":0.004648},{"month":10,"riseRate":0.56,"avgChangeRate":0.002735},{"month":11,"riseRate":0.6,"avgChangeRate":-0.001321},{"month":12,"riseRate":0.666667,"avgChangeRate":0.029189}],"exchange":"NASDAQ","name":"赛诺菲安万特","nameEN":"Sanofi SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛诺菲安万特,SNY,赛诺菲安万特股票,赛诺菲安万特股票老虎,赛诺菲安万特股票老虎国际,赛诺菲安万特行情,赛诺菲安万特股票行情,赛诺菲安万特股价,赛诺菲安万特股市,赛诺菲安万特股票价格,赛诺菲安万特股票交易,赛诺菲安万特股票购买,赛诺菲安万特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}